Nanjing Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Nanjing Mailland Medical Technology Co., Ltd.
Apr 30 12:00 ET
2024 First Quarter Report
Apr 25 12:00 ET
Notice on amending the company's articles of association and registration of industrial and commercial changes
Apr 25 12:00 ET
“Constitution of Nanjing Maillander Medical Technology Co., Ltd.”
Apr 25 12:00 ET
Nanjing Securities Co., Ltd. inspection opinions on Nanjing Mailland Medical Technology Co., Ltd.'s use of temporarily idle funds to purchase wealth management products
Apr 25 12:00 ET
Notice on Using Temporary Idle Own Funds to Purchase Wealth Management Products
Apr 25 12:00 ET
Notice on applying for comprehensive credit lines from financial institutions in 2024
Apr 25 12:00 ET
Announcement of Resolutions of the Fifth Meeting of the Second Board of Directors
Apr 25 12:00 ET
Notice on convening the 2023 Annual General Meeting of Shareholders
Apr 25 12:00 ET
2023 Annual Report Summary
Apr 25 12:00 ET
2023 ANNUAL REPORT
Apr 25 12:00 ET
2023 Audit Report
Apr 25 12:00 ET
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Nanjing Mailander Medical Technology Co., Ltd.
Apr 25 12:00 ET
2023 Independent Director Debriefing Report (Yuan Tianrong)
Apr 25 12:00 ET
2023 Internal Control Audit Report
Apr 25 12:00 ET
Nanjing Securities Co., Ltd.'s inspection opinion on Nanjing Mailland Medical Technology Co., Ltd.'s use of part of the overraised capital to permanently supplement working capital
Apr 25 12:00 ET
Announcement of Resolutions of the Fourth Meeting of the Second Board of Supervisors
Apr 25 12:00 ET
2023 Internal Control Evaluation Report
Apr 25 12:00 ET
2023 Board Audit Committee Performance Report
Apr 25 12:00 ET
Special report of the board of directors on the self-inspection of the independence of independent directors
Apr 25 12:00 ET
No Data
No Data